Skip to content

Adaptive Biotechnologies ADPT Change in Other Assets

Change in Other Assets at other companies

Guardant Health logo
Guardant HealthGH
$7.24M+136%
Natera, Inc. logo
Natera, Inc.NTRA
$17.06M+82.4%
Veracyte logo
VeracyteVCYT
$132K+208%
Danaher logo
DanaherDHR
$40M+25.0%
Arrowhead Research logo
Arrowhead ResearchARWR
$13.18M+2,127%
Vera Therapeutics logo
Vera TherapeuticsVERA
$5.14M-12.5%

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's change in other assets?
Adaptive Biotechnologies (ADPT) reported change in other assets of $824K in Q1 2026.
How has Adaptive Biotechnologies's change in other assets changed year-over-year?
Adaptive Biotechnologies's change in other assets increased by 268.5% year-over-year, from -$489K to $824K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.